You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
It is possible that some of the products on the other site are not approved in your region or country.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations, except those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011, article 34.
Click “OK” to confirm you are a Healthcare Professional.
Meet the first-of-its-kind
Navigate the power of sensing with the world's most advanced
and innovative DBS system.
Supporting better Parkinson's outcomes
through more objective referral insights.
The Activa™ RC and Activa™ SC neurostimulators are
full-body MR Conditional† with advanced programming options.
Learn the parameters of patient selection for Parkinson’s disease, epilepsy, essential tremor, dystonia, and OCD.VIEW INDICATIONS
DBS for Parkinson's
Information for your patients on DBS therapy for Parkinson's disease, including patient stories.View website
Medtronic MR Conditional† DBS systems are backed by more than 14 years of MRI research and testing history.1LEARN ABOUT MRI
Access the Medical Education Program for Health Care Professionals in the field of movement disorders and epilepsy.Visit our Medical Education site
Medtronic data on file: Report; NDHF1443-128376 - DBS Expanded MRI Labeling RF Lead Heating Design Verification Test Report
Medtronic’s Activa™ PC+S device received CE Mark on January 17, 2013, but was not commercially distributed.
Medtronic DBS systems are MR Conditional and safe in the MR environment as long as certain conditions are met. If the conditions are not met, a significant risk is tissue lesions from component heating, especially at the lead electrodes, resulting in serious and permanent injury including coma, paralysis, or death. Refer to the MRI Guidelines for Medtronic Deep Brain Stimulation Systems at www.medtronic.com/mri or contact Medtronic at +44 (0) 1923 205101 for a complete list of conditions. Also review current MRI manufacturer labeling before conducting the MRI.
See the device manual for detailed information regarding the instructions for use, indications, contraindications, warnings, precautions, and potential adverse events. If using an MRI SureScan® device, see the MRI SureScan® technical manual before performing an MRI. For further information, contact your local Medtronic representative and/or consult the Medtronic website at medtronic.eu.